Evaluation of the carcinogenic and genotoxic potential of praziquantel in the Syrian hamster embryo cell transformation assay
- 1 March 1994
- journal article
- Published by Elsevier in Mutation Research
- Vol. 305 (2), 175-180
- https://doi.org/10.1016/0027-5107(94)90237-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: III. Cell transformation in C3H/10T1/2 mouse embryo cell, BALB/c 3T3 mouse fibroblast and Syrian hamster embryo cell culturesMutation Research, 1991
- Plasma and CSF Levels of Albendazole and Praziquantel in Patients with NeurocysticercosisClinical Neuropharmacology, 1990
- Enhancement of benzene clastogenicity by praziquantel in miceMutation Research/Genetic Toxicology, 1989
- 2-Nitropropane induces DNA repair synthesis in rat hepatocytes in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 1988
- A simple and reliable in vitro test system for the analysis of induced aneuploidy as well as other cytogenetic end-points using Chinese hamster cellsMutagenesis, 1986
- The size of micronuclei in human lymphocytes varies according to inducing agent usedMutation Research/Genetic Toxicology, 1985
- Characterization of an unscheduled DNA synthesis assay with Syrian hamster embryo cellsMutation Research, 1984
- Induction of morphological transformation and unscheduled DNA synthesis in Syrian hamster embryo fibroblasts by hexachlorobutadiene and its putative metabolite pentachlorobutenoic acidCancer Letters, 1984
- Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal drug, in bacteria, yeasts, insects and mammalian cellsMutation Research/Genetic Toxicology, 1978
- Evidence for repair-replication of ultraviolet damaged DNA in bacteriaJournal of Molecular Biology, 1964